Evoke Pharma Inc. (EVOK): HA! Let's see this thing rise throughou...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	241
Posts	16076
Boards Moderated	1
Alias Born	09/16/2005

stock_observer_77

Re: logic_guy post# 920

Monday, 08/15/2016 9:07:08 AM

Monday, August 15, 2016 9:07:08 AM

HA! Let's see this thing rise throughout the day!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent EVOK News

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/01/2024 08:53:00 PM
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion • GlobeNewswire Inc. • 10/01/2024 12:30:18 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/27/2024 09:11:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 09:08:06 PM
Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/20/2024 11:28:39 PM
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments • GlobeNewswire Inc. • 09/19/2024 06:20:38 PM
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference • GlobeNewswire Inc. • 09/09/2024 12:30:08 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:04 AM
Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:20:55 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/29/2024 08:16:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 11:00:08 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/13/2024 09:01:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:20:07 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:15:18 PM
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:00:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:11:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:51:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:48:45 PM
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month • GlobeNewswire Inc. • 08/08/2024 12:30:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:09 AM
Evoke Pharma, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 07/30/2024 12:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:01:20 AM
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI • GlobeNewswire Inc. • 06/17/2024 12:30:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:00:09 PM

More EVOK News

InvestorsHub NewsWire

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM

Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM

ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM

Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover